Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | KDM4A | O75164 | 2/20 | 0.62 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.62 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.59 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.50 |
| ▸ | KDM6B | O15054 | 1/20 | 0.50 |
| ▸ | KDM6A | O15550 | 1/20 | 0.50 |
| ▸ | TET3 | O43151 | 1/20 | 0.50 |
| ▸ | KDM4B | O94953 | 1/20 | 0.50 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30744764 | 0.88 | KDM4E (0.62) | L3MBTL1KDM4EKDM4AEGLN1RAB9A | |
| SCHEMBL22492328 | 0.84 | PSMD14 (0.64) | L3MBTL1KDM4EKDM4AEGLN1RAB9A | |
| SCHEMBL3501677 | 0.80 | TAS2R14 (0.63) | GSK3AGSK3BDYRK3PRKD3MAP4K4 | |
| SCHEMBL69905 | 0.80 | KDM4E (0.74) | L3MBTL1KDM4EKDM4AEGLN1RAB9A | |
| SCHEMBL10957645 | 0.79 | TAS2R14 (0.62) | GSK3AGSK3BDYRK3PRKD3MAP4K4 | |
| SCHEMBL10957630 | 0.79 | TAS2R14 (0.62) | GSK3AGSK3BDYRK3PRKD3MAP4K4 | |
| Hydrochloric Acid SCHEMBL11252208 | 0.79 | TAS2R14 (0.62) | GSK3AGSK3BDYRK3PRKD3MAP4K4 | |
| SCHEMBL1125190 | 0.79 | NR1H2 (0.57) | NR1H2NR1H3GSK3AGSK3BDYRK3 | |
| SCHEMBL7373143 | 0.79 | KDM4E (0.68) | L3MBTL1KDM4EKDM4AEGLN1RAB9A | |
| SCHEMBL5761539 | 0.79 | KDM4E (0.68) | L3MBTL1KDM4EKDM4AEGLN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1835944-A | Quinolyl amide derivatives as CCR-5 antagonists | SCHERING AG (DE) | 2006-09-20 | — | — | CN | disclosed |
| EP-1633737-A1 | QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-03-15 | — | — | EP | disclosed |
| US-20050020605-A1 | Quinolyl amide derivatives as CCR-5 antagonists | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| WO-2004113323-A1 | QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-12-29 | — | — | WO | disclosed |
| US-4970214-A | DIABETIC COMPLICATIONS | NIPPON SHINYAKU CO., LTD. (JP) | 1990-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020605-A1 | Quinolyl amide derivatives as CCR-5 antagonists | CCRL2, CCR5, CCR1 | L3MBTL1 3148/4885KDM4E 2423/4885KDM4A 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.